Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Nutrition|June 26, 2024
The state of the science on the health benefits of blueberries: a perspectiveApril J Stull, Aedín Cassidy, Luc Djousse, et al.Clinical Lymphoma, Myeloma & Leukemia|December 28, 2020
Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell LymphomaSolomon A Graf, Ryan D Cassaday, Karolyn Morris, et al.Blood Advances|November 17, 2022
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHLSolomon A Graf, Ryan C Lynch, Chaitra S Ujjani, et al.Scientific Data|June 2, 2023
Curated and harmonized gut microbiome 16S rRNA amplicon data from dietary fiber intervention studies in humansCynthia I Rodriguez, Ali Keshavarzian, Bruce R Hamaker, et al.The Lancet. Haematology|July 30, 2021
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 studyRyan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.Blood Advances|December 15, 2022
Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomasRyan C Lynch, Christina Poh, Chaitra S Ujjani, et al.Blood|March 13, 2023
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphomaRyan C Lynch, Chaitra S Ujjani, Christina Poh, et al.JCI Insight|June 21, 2022
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signalingLeila B Giron, Michael J Peluso, Jianyi Ding, et al.Pageof 2